BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de la Portilla F, Jiménez-salido A, Araujo-miguez A, Maestre-sanchez MV, Reyes-diaz ML, Ramallo-solís I, Ramos-fernández M, Vázquez-monchul JM, García-cabrera AM, Jimenez-rodríguez RM, Díaz-pavón JM, Padillo-ruiz FJ. Autologous Platelet-Rich Plasma in the Treatment of Perianal Fistula in Crohn’s Disease. J Gastrointest Surg 2020;24:2814-21. [DOI: 10.1007/s11605-019-04480-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 de la Portilla F. Reply to Balaphas et al. Colorectal Dis 2021;23:1002-3. [PMID: 33427388 DOI: 10.1111/codi.15527] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Luo Q, Zhou P, Chang S. Meta‐analysis of platelet‐rich plasma therapy for anal fistula. J of Cosmetic Dermatology. [DOI: 10.1111/jocd.14760] [Reference Citation Analysis]
3 Madbouly KM, Emile SH, Issa YA, Omar W. Ligation of intersphincteric fistula tract (LIFT) with or without injection of platelet-rich plasma (PRP) in management of high trans-sphincteric fistula-in-ano: Short-term outcomes of a prospective, randomized trial. Surgery 2021;170:61-6. [PMID: 33536119 DOI: 10.1016/j.surg.2020.12.025] [Reference Citation Analysis]
4 Fitzpatrick DP, Kealey C, Brady D, Goodman M, Gately N. Treatments for the amelioration of persistent factors in complex anal fistula. Biotechnol Lett 2021. [PMID: 34799826 DOI: 10.1007/s10529-021-03207-w] [Reference Citation Analysis]